{"title":"Re: Validation of the Emergency Surgery Acuity Score in Patients Who Underwent Emergency General Surgery in South Korea: A Multi-Center, Retrospective, Post Hoc Analysis.","authors":"Hengying Chen, Zhehao Wu, Ze Bo, Mingshan Liu","doi":"10.1111/ans.70417","DOIUrl":"https://doi.org/10.1111/ans.70417","url":null,"abstract":"","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145676356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ruelan Furtado, Laurence Weinberg, Koroush S Haghighi, David Burnett, Daniel Croagh, Vijayaragavan Muralidharan, Charles H C Pilgrim, Mithra Sritharan, Marty Smith, Marcos V Perini, Osamu Yoshino, Michael A Fink, Robert Jones, Vincent Lam, Lawrence Yuen, Daniel Daly, Robert C Gandy, Ee Jun Ban, Nezor Houli, Russell Hodgson, Benjamin J Privett, Mehrdad Nikfarjam
Background: Postoperative pancreatic fistula (POPF) is the primary cause of morbidity after distal pancreatectomy (DP). This trial investigated the application of a combined polyethylene glycol (PEG) and recombinant human albumin sealant gel to the stapled, transected pancreatic margin to reduce clinically significant POPF.
Methods: A multicenter randomised controlled trial in patient candidates for DP with stapled transection was conducted. Participants were randomised to receive DP with or without PEG sealant applied to the stapled margin. The primary outcome was clinically significant POPF. Secondary outcomes included other complications, length of hospital stay and 90-day mortality.
Results: Seventy-eight patients with completed DP were included, 38 of whom underwent stapled DP combined with the use of PEG sealant (PEG group). No significant differences between the two groups were observed with respect to pathology type, operative approach or operative time. The PEG group exhibited significantly fewer complications (18% vs. 50% in the control group; p = 0.003), and a lower rate of POPF (11% vs. 28%; p = 0.08, respectively). Multivariate analysis revealed a significant association between spleen preservation and the rate of clinically significant fistula (OR 4.4; 95% CI 1.1-18.0; p = 0.038). The rate of POPF was lower in the PEG group but did not reach statistical significance (OR 0.3; 95% CI 0.1-1.2; p = 0.091).
Conclusion: Stapled DP combined with PEG application was associated with reduced complications. There was a lower rate of POPF in the PEG sealant group that did not reach statistical significance.
Australian new zealand clinical trials registry: ACTRN12620001336976p.
背景:术后胰瘘(POPF)是远端胰腺切除术(DP)后发病的主要原因。本试验研究了将聚乙二醇(PEG)和重组人白蛋白密封凝胶联合应用于缝合的胰腺边缘,以减少临床上显著的POPF。方法:采用多中心随机对照试验,对伴有缝合性横断的DP候选患者进行研究。参与者随机接受DP,或不使用PEG密封剂应用于装订的边缘。主要结果为临床显著的POPF。次要结局包括其他并发症、住院时间和90天死亡率。结果:纳入78例完成DP的患者,其中38例进行了钉接DP并使用PEG密封剂(PEG组)。两组在病理类型、手术入路、手术时间等方面均无明显差异。PEG组并发症明显减少(18% vs. 50%, p = 0.003), POPF发生率较低(11% vs. 28%, p = 0.08)。多因素分析显示,脾脏保存与临床显著瘘发生率之间存在显著相关性(OR 4.4; 95% CI 1.1-18.0; p = 0.038)。PEG组的POPF发生率较低,但差异无统计学意义(OR 0.3; 95% CI 0.1 ~ 1.2; p = 0.091)。结论:钉钉DP联合PEG应用可减少并发症。聚乙二醇组的POPF发生率较低,但差异无统计学意义。澳大利亚新西兰临床试验注册:ACTRN12620001336976p。
{"title":"A Biodegradable Polymeric Sealant Applied to Transected Margin Following Stapled Distal Pancreatectomy Reduces Overall Complication: A Randomised Controlled Trial.","authors":"Ruelan Furtado, Laurence Weinberg, Koroush S Haghighi, David Burnett, Daniel Croagh, Vijayaragavan Muralidharan, Charles H C Pilgrim, Mithra Sritharan, Marty Smith, Marcos V Perini, Osamu Yoshino, Michael A Fink, Robert Jones, Vincent Lam, Lawrence Yuen, Daniel Daly, Robert C Gandy, Ee Jun Ban, Nezor Houli, Russell Hodgson, Benjamin J Privett, Mehrdad Nikfarjam","doi":"10.1111/ans.70419","DOIUrl":"https://doi.org/10.1111/ans.70419","url":null,"abstract":"<p><strong>Background: </strong>Postoperative pancreatic fistula (POPF) is the primary cause of morbidity after distal pancreatectomy (DP). This trial investigated the application of a combined polyethylene glycol (PEG) and recombinant human albumin sealant gel to the stapled, transected pancreatic margin to reduce clinically significant POPF.</p><p><strong>Methods: </strong>A multicenter randomised controlled trial in patient candidates for DP with stapled transection was conducted. Participants were randomised to receive DP with or without PEG sealant applied to the stapled margin. The primary outcome was clinically significant POPF. Secondary outcomes included other complications, length of hospital stay and 90-day mortality.</p><p><strong>Results: </strong>Seventy-eight patients with completed DP were included, 38 of whom underwent stapled DP combined with the use of PEG sealant (PEG group). No significant differences between the two groups were observed with respect to pathology type, operative approach or operative time. The PEG group exhibited significantly fewer complications (18% vs. 50% in the control group; p = 0.003), and a lower rate of POPF (11% vs. 28%; p = 0.08, respectively). Multivariate analysis revealed a significant association between spleen preservation and the rate of clinically significant fistula (OR 4.4; 95% CI 1.1-18.0; p = 0.038). The rate of POPF was lower in the PEG group but did not reach statistical significance (OR 0.3; 95% CI 0.1-1.2; p = 0.091).</p><p><strong>Conclusion: </strong>Stapled DP combined with PEG application was associated with reduced complications. There was a lower rate of POPF in the PEG sealant group that did not reach statistical significance.</p><p><strong>Australian new zealand clinical trials registry: </strong>ACTRN12620001336976p.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145676306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Acute pancreatitis (AP) is a catabolic disease with a risk of prolonged hospital stay. Patients are at risk of sarcopenia. However, the impact of sarcopenia on clinical outcomes post-AP is poorly explored.
Methods: A search of PUBMED, MEDLINE, and EMBASE databases was performed, and studies published between January 1990 and October 2024 were included.
Results: Ten studies with 2841 patients with a median age of 56.3 years were included. The number of patients with mild, moderate, and severe AP were 771, 545, and 399, respectively. Nine studies used skeletal muscle mass/skeletal muscle index/skeletal muscle attenuation, and one used visceral fat/muscle mass ratio as indicators of sarcopenia, measuring muscle mass at L3 vertebra or measuring psoas muscle volume. One longitudinal study reported that 80% of patients with severe AP were sarcopenic at 12 months. There was a strong correlation between sarcopenia and adverse clinical outcomes and mortality. There is no data on the impact of sarcopenia on quality of life (QOL).
Conclusion: This review suggests an association between sarcopenia and the severity of AP in addition to worse postpancreatitis outcomes. Further prospective studies are needed with standardized definitions for sarcopenia with longitudinal follow-up reporting on QOL.
{"title":"Clinical Impact of Sarcopenia and Sarcopenic Obesity in Acute Pancreatitis: A Systematic Review.","authors":"Matta Kuzman, Nejo Joseph, Ramy Nafady, Olivia Kent, Tanmay Tarigonda, Sanjay Pandanaboyana","doi":"10.1111/ans.70422","DOIUrl":"https://doi.org/10.1111/ans.70422","url":null,"abstract":"<p><strong>Background: </strong>Acute pancreatitis (AP) is a catabolic disease with a risk of prolonged hospital stay. Patients are at risk of sarcopenia. However, the impact of sarcopenia on clinical outcomes post-AP is poorly explored.</p><p><strong>Methods: </strong>A search of PUBMED, MEDLINE, and EMBASE databases was performed, and studies published between January 1990 and October 2024 were included.</p><p><strong>Results: </strong>Ten studies with 2841 patients with a median age of 56.3 years were included. The number of patients with mild, moderate, and severe AP were 771, 545, and 399, respectively. Nine studies used skeletal muscle mass/skeletal muscle index/skeletal muscle attenuation, and one used visceral fat/muscle mass ratio as indicators of sarcopenia, measuring muscle mass at L3 vertebra or measuring psoas muscle volume. One longitudinal study reported that 80% of patients with severe AP were sarcopenic at 12 months. There was a strong correlation between sarcopenia and adverse clinical outcomes and mortality. There is no data on the impact of sarcopenia on quality of life (QOL).</p><p><strong>Conclusion: </strong>This review suggests an association between sarcopenia and the severity of AP in addition to worse postpancreatitis outcomes. Further prospective studies are needed with standardized definitions for sarcopenia with longitudinal follow-up reporting on QOL.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145686956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Minimally invasive oesphagectomy has been found to reduce complications, length of stay and have improved post-operative quality of life compared to open oesophagectomy. Multiple techniques of the oesophagogastric anastomosis have been described in Australia including a three-stage approach with a neck anastomosis and a two-stage approach utilising the trans-orally placed anvil. We describe a two-stage approach with an intra-thoracic hand-sewn anastomosis for a junctional oesophageal cancer.
{"title":"How I do an Intrathoracic Hand-Sewn Anastomosis During a Minimally Invasive Oesophagectomy.","authors":"Aadil Rahim, Michael Devadas","doi":"10.1111/ans.70414","DOIUrl":"https://doi.org/10.1111/ans.70414","url":null,"abstract":"<p><p>Minimally invasive oesphagectomy has been found to reduce complications, length of stay and have improved post-operative quality of life compared to open oesophagectomy. Multiple techniques of the oesophagogastric anastomosis have been described in Australia including a three-stage approach with a neck anastomosis and a two-stage approach utilising the trans-orally placed anvil. We describe a two-stage approach with an intra-thoracic hand-sewn anastomosis for a junctional oesophageal cancer.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145666883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rachelle Buchbinder, Richard S Page, Jonathan G Quicke, Nadine E Foster, Manuela L Ferreira, Ian A Harris
{"title":"Australia Is Not Surgical Trial Ready.","authors":"Rachelle Buchbinder, Richard S Page, Jonathan G Quicke, Nadine E Foster, Manuela L Ferreira, Ian A Harris","doi":"10.1111/ans.70411","DOIUrl":"https://doi.org/10.1111/ans.70411","url":null,"abstract":"","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145653520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Re: The Impact of High Complexity Total Pelvic Exenteration on Surgeon Fatigue: The FaME Study.","authors":"Pengtao Hu, Hanzhi Sun, Chengyu Lv","doi":"10.1111/ans.70420","DOIUrl":"https://doi.org/10.1111/ans.70420","url":null,"abstract":"","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145653558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Daniel Crisafi, Anne Hong, Nathan Papa, Fabian Obrecht, Kirby R Qin, Joel Ding, Marcos Vinicius Perini, Siven Seevanayagam, Peter McCall, Jason Chuen, Sara Qi, Gregory Jack, Joseph Ischia, Damien Bolton, Dixon T S Woon
Background: Renal vein and caval tumour extension occurs in 10%-25% of patients with renal cell carcinoma. This study aims to examine perioperative morbidity and survival outcomes after radical nephrectomy with inferior vena cava tumour thrombectomy at a quaternary institution in Australia.
Methods: This was a retrospective review of nephrectomy with tumour thrombectomy cases between June 2012 and 2022 at a single centre, followed up until September 2024. Overall survival (OS) was visualised by Kaplan-Meier plots and comparisons between survival by presence of metastases, margin status, and thrombus level (I-III vs. IV) were explored with the log-rank test. Recurrence-free survival (RFS) in patients without initial metastases was also examined.
Results: We identified 39 patients, 25 (64%) were male and the median (IQR) age was 64 years (55-69). Metastatic disease was present in 14 patients (36%). Nineteen (49%) had level IV (supradiaphragmatic) tumour thrombus involvement. Six patients (15%) died in hospital, including two intraoperative deaths. A further 14 (36%) experienced Clavien-Dindo grade III or IV complications during their hospital stay. The median OS was 57 months (95% CI: 17-not reached). Excluding those who died in hospital, the median OS was 60 months (95% CI: 33-not reached). There was a significant difference in OS observed by the presence of metastatic disease (p = 0.003), but not with margin status (p = 0.35) or thrombus level (p = 0.22). The median RFS for M0 patients was 60 months (95% CI: 8-not reached).
Conclusion: While associated with high morbidity and mortality, nephrectomy and caval thrombectomy remain an effective treatment option for otherwise fatal advanced RCC.
{"title":"Outcomes of Radical Nephrectomy With Caval Tumour Thrombectomy Including a Novel Two-Stage Approach.","authors":"Daniel Crisafi, Anne Hong, Nathan Papa, Fabian Obrecht, Kirby R Qin, Joel Ding, Marcos Vinicius Perini, Siven Seevanayagam, Peter McCall, Jason Chuen, Sara Qi, Gregory Jack, Joseph Ischia, Damien Bolton, Dixon T S Woon","doi":"10.1111/ans.70404","DOIUrl":"https://doi.org/10.1111/ans.70404","url":null,"abstract":"<p><strong>Background: </strong>Renal vein and caval tumour extension occurs in 10%-25% of patients with renal cell carcinoma. This study aims to examine perioperative morbidity and survival outcomes after radical nephrectomy with inferior vena cava tumour thrombectomy at a quaternary institution in Australia.</p><p><strong>Methods: </strong>This was a retrospective review of nephrectomy with tumour thrombectomy cases between June 2012 and 2022 at a single centre, followed up until September 2024. Overall survival (OS) was visualised by Kaplan-Meier plots and comparisons between survival by presence of metastases, margin status, and thrombus level (I-III vs. IV) were explored with the log-rank test. Recurrence-free survival (RFS) in patients without initial metastases was also examined.</p><p><strong>Results: </strong>We identified 39 patients, 25 (64%) were male and the median (IQR) age was 64 years (55-69). Metastatic disease was present in 14 patients (36%). Nineteen (49%) had level IV (supradiaphragmatic) tumour thrombus involvement. Six patients (15%) died in hospital, including two intraoperative deaths. A further 14 (36%) experienced Clavien-Dindo grade III or IV complications during their hospital stay. The median OS was 57 months (95% CI: 17-not reached). Excluding those who died in hospital, the median OS was 60 months (95% CI: 33-not reached). There was a significant difference in OS observed by the presence of metastatic disease (p = 0.003), but not with margin status (p = 0.35) or thrombus level (p = 0.22). The median RFS for M0 patients was 60 months (95% CI: 8-not reached).</p><p><strong>Conclusion: </strong>While associated with high morbidity and mortality, nephrectomy and caval thrombectomy remain an effective treatment option for otherwise fatal advanced RCC.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145647225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Caroline Lam, Collette Massy-Westropp, Stuart Hamilton
Background: While studies have explored the gender gap in scientific literature, there is a scarcity of information on the impact within surgical publications. We examine the gender gap in Plastic and Reconstructive Surgery papers across two prominent Australasian journals.
Methods: All original clinical science articles published in AJOPS and ANZ Journal of Surgery were reviewed from 2018 to 2024. The gender of the first and last authors, as well as the subspecialty category, type of paper, journal volume, year and issue were entered in a database for further analysis. In addition, we examined whether first author gender was correlated to the gender of the senior faculty with whom they were co-authored.
Results: A total of 344 papers met the inclusion criteria for the study. Male authorship was more prevalent accounting for 65% in comparison to female authorship at 35%. When selecting for editorials only, male first authors accounted for 83% (43) versus female first authors at 17% (10). Excluding editorials, male first authorship reached 62% (183) while females made up the remaining 38% (108). In terms of senior authorship, males accounted for 80% (234) versus 20% (59).
Conclusion: Despite some fluctuation, our findings demonstrate a persistent disequilibrium in gender representation in the chosen journals which likely reflects the current disparity in the profession. Whether the increased recruitment and retention of female trainees and surgeons, is gradually translating to publication output, is not entirely understood. Further research is needed to identify and address the barriers to publication experienced by women in plastic surgery.
背景:虽然有研究探讨了科学文献中的性别差距,但在外科出版物中缺乏关于其影响的信息。我们检查性别差距在整形和重建外科论文在两个著名的澳大利亚期刊。方法:回顾2018 - 2024年发表在《AJOPS》和《ANZ Journal of Surgery》上的所有临床科学原创文章。第一和最后作者的性别,以及亚专业类别、论文类型、期刊卷数、年份和发行期被输入数据库以供进一步分析。此外,我们还检查了第一作者的性别是否与他们共同撰写的高级教师的性别相关。结果:共有344篇论文符合本研究的纳入标准。男性作者占65%,而女性作者占35%。当只选择社论时,男性第一作者占83%(43),而女性第一作者占17%(10)。除去社论,男性第一作者占62%(183篇),女性占38%(108篇)。在资深作者方面,男性占80%(234),男性占20%(59)。结论:尽管有一些波动,但我们的研究结果表明,在所选期刊中,性别代表性持续不平衡,这可能反映了当前该行业的差距。女性受训人员和外科医生的增加招聘和保留是否逐渐转化为出版物产出,目前还不完全清楚。需要进一步的研究来确定和解决女性在整形手术中遇到的发表障碍。
{"title":"Gender Gaps in Publication: Plastic Surgery in Australasia.","authors":"Caroline Lam, Collette Massy-Westropp, Stuart Hamilton","doi":"10.1111/ans.70410","DOIUrl":"https://doi.org/10.1111/ans.70410","url":null,"abstract":"<p><strong>Background: </strong>While studies have explored the gender gap in scientific literature, there is a scarcity of information on the impact within surgical publications. We examine the gender gap in Plastic and Reconstructive Surgery papers across two prominent Australasian journals.</p><p><strong>Methods: </strong>All original clinical science articles published in AJOPS and ANZ Journal of Surgery were reviewed from 2018 to 2024. The gender of the first and last authors, as well as the subspecialty category, type of paper, journal volume, year and issue were entered in a database for further analysis. In addition, we examined whether first author gender was correlated to the gender of the senior faculty with whom they were co-authored.</p><p><strong>Results: </strong>A total of 344 papers met the inclusion criteria for the study. Male authorship was more prevalent accounting for 65% in comparison to female authorship at 35%. When selecting for editorials only, male first authors accounted for 83% (43) versus female first authors at 17% (10). Excluding editorials, male first authorship reached 62% (183) while females made up the remaining 38% (108). In terms of senior authorship, males accounted for 80% (234) versus 20% (59).</p><p><strong>Conclusion: </strong>Despite some fluctuation, our findings demonstrate a persistent disequilibrium in gender representation in the chosen journals which likely reflects the current disparity in the profession. Whether the increased recruitment and retention of female trainees and surgeons, is gradually translating to publication output, is not entirely understood. Further research is needed to identify and address the barriers to publication experienced by women in plastic surgery.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145647296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lara Wirth, Eloise Cooper, Xiang Quan Chan, Ranjit Singh, Matthew Wei, Evelyn Hutcheon, Rory Kokelaar, Justin M Yeung
Background: Colorectal cancer liver metastasis (CRCLM) profoundly impacts the overall survival rates of affected individuals. Although chemotherapy remains a cornerstone of treatment, the variability in tumour response presents a considerable challenge to effective clinical management. Radiomics-based artificial intelligence (AI) modelling, utilising pre-treatment imaging, has been proposed as a tool to predict treatment response and inform therapeutic decision-making.
Methods: A systematic search using Clarivate (Web of Science) and Ovid (Embase and MEDLINE) from inception to April 8, 2025, was performed in accordance with Preferred Reporting Items for Reviews and Meta-Analysis (PRISMA) guidelines. Studies evaluating the use of AI radiomics models to predict CRCLM response to chemotherapy treatment, alone or in combination with targeted therapies were identified. Full-text review and data extraction were performed independently by two reviewers. Risk of bias was assessed using the Checklist for Diagnostic Test Accuracy Studies.
Results: Thirteen studies met inclusion criteria. All studies described the development and validation of AI models with no implementation studies. The AI models developed demonstrated a varied ability to predict CRCLM response to chemotherapy. Predictive performance was classified as good in six studies and excellent in three. Model development used differing combinations of imaging modalities (CT or MRI), lesion inclusion criteria, dimensionality (2D vs. 3D), and use of clinical features. Most studies did not validate model performance in an external dataset.
Conclusion: Radiomics-based AI models show potential in predicting chemotherapy response in CRCLM. However, limited external validation and methodological variability currently restrict clinical applicability. Standardisation and prospective validation are required for clinical translation.
背景:结直肠癌肝转移(CRCLM)严重影响患者的总体生存率。虽然化疗仍然是治疗的基石,但肿瘤反应的可变性对有效的临床管理提出了相当大的挑战。基于放射组学的人工智能(AI)建模,利用治疗前成像,已被提出作为预测治疗反应和告知治疗决策的工具。方法:使用Clarivate (Web of Science)和Ovid (Embase和MEDLINE)从成立到2025年4月8日进行系统检索,按照优先报告项目进行综述和荟萃分析(PRISMA)指南。研究评估了使用AI放射组学模型预测CRCLM对化疗的反应,无论是单独治疗还是联合靶向治疗。全文审查和数据提取由两名审稿人独立完成。使用诊断测试准确性研究检查表评估偏倚风险。结果:13项研究符合纳入标准。所有研究都描述了人工智能模型的开发和验证,没有实施研究。开发的人工智能模型显示出预测CRCLM对化疗反应的不同能力。预测性能在6项研究中被归类为良好,在3项研究中被归类为优秀。模型开发使用不同的成像方式(CT或MRI)、病变包含标准、维度(2D vs 3D)和临床特征的组合。大多数研究没有在外部数据集中验证模型的性能。结论:基于放射组学的AI模型在预测CRCLM化疗反应方面具有潜力。然而,有限的外部验证和方法可变性目前限制了临床应用。临床翻译需要标准化和前瞻性验证。
{"title":"Radiomic Artificial Intelligence Models Predicting the Response of Colorectal Cancer Liver Metastases to Chemotherapy-A Systematic Review.","authors":"Lara Wirth, Eloise Cooper, Xiang Quan Chan, Ranjit Singh, Matthew Wei, Evelyn Hutcheon, Rory Kokelaar, Justin M Yeung","doi":"10.1111/ans.70412","DOIUrl":"https://doi.org/10.1111/ans.70412","url":null,"abstract":"<p><strong>Background: </strong>Colorectal cancer liver metastasis (CRCLM) profoundly impacts the overall survival rates of affected individuals. Although chemotherapy remains a cornerstone of treatment, the variability in tumour response presents a considerable challenge to effective clinical management. Radiomics-based artificial intelligence (AI) modelling, utilising pre-treatment imaging, has been proposed as a tool to predict treatment response and inform therapeutic decision-making.</p><p><strong>Methods: </strong>A systematic search using Clarivate (Web of Science) and Ovid (Embase and MEDLINE) from inception to April 8, 2025, was performed in accordance with Preferred Reporting Items for Reviews and Meta-Analysis (PRISMA) guidelines. Studies evaluating the use of AI radiomics models to predict CRCLM response to chemotherapy treatment, alone or in combination with targeted therapies were identified. Full-text review and data extraction were performed independently by two reviewers. Risk of bias was assessed using the Checklist for Diagnostic Test Accuracy Studies.</p><p><strong>Results: </strong>Thirteen studies met inclusion criteria. All studies described the development and validation of AI models with no implementation studies. The AI models developed demonstrated a varied ability to predict CRCLM response to chemotherapy. Predictive performance was classified as good in six studies and excellent in three. Model development used differing combinations of imaging modalities (CT or MRI), lesion inclusion criteria, dimensionality (2D vs. 3D), and use of clinical features. Most studies did not validate model performance in an external dataset.</p><p><strong>Conclusion: </strong>Radiomics-based AI models show potential in predicting chemotherapy response in CRCLM. However, limited external validation and methodological variability currently restrict clinical applicability. Standardisation and prospective validation are required for clinical translation.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145647220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hikmet Pehlevan-Özel, Zeynep Nur Yurdakul, Hüseyin Fahri Martlı, Sabiha Nur Özmen, Sadettin Er, Erdinç Çetinkaya, Tezcan Akın, Özgür Akgül
Background: Transanal opening of the intersphincteric space (TROPIS) has recently emerged as a sphincter-preserving option for the treatment of complex anal fistulas. Although high success rates have been reported in large international series, data on long-term real-world outcomes remain limited. This study aimed to evaluate long-term results of TROPIS, focusing on recurrence and continence, and to compare them with existing literature.
Methods: This retrospective single-center cohort included 28 patients who underwent the TROPIS procedure between 2020 and 2023. Demographic data, Parks classification of fistula, operative details, recurrence rates, healing times, and continence outcomes were analyzed. Recurrence was defined as the reappearance of fistula after initial complete healing. Continence was assessed using the Wexner score. Patients were followed with a mean follow-up of 680 ± 120 days.
Results: The mean age was 42.6 years. According to Parks' classification, 21 patients (75%) had transsphincteric, 5 (17.9%) extrasphincteric, and 2 (7.1%) complex transsphincteric (horseshoe variant). The average healing time was 36 days. No recurrence occurred within the first 90 days; thereafter, 9 patients (32.1%) developed recurrence (median 225 days, range 90-660). Early postoperative mild incontinence occurred in 42.9% of patients, but only 5 (17.8%) reported persistent mild symptoms at long-term follow-up. No major incontinence was recorded.
Conclusion: TROPIS appears to be a safe, sphincter-preserving technique for complex anal fistulas, providing acceptable healing with preserved continence. However, recurrence rates in this cohort were higher than those reported internationally, underscoring the need for careful patient selection, surgical expertise, and adequate long-term follow-up.
{"title":"TROPIS Procedure in Complex Anal Fistulas: Single-Center Long-Term Results.","authors":"Hikmet Pehlevan-Özel, Zeynep Nur Yurdakul, Hüseyin Fahri Martlı, Sabiha Nur Özmen, Sadettin Er, Erdinç Çetinkaya, Tezcan Akın, Özgür Akgül","doi":"10.1111/ans.70397","DOIUrl":"https://doi.org/10.1111/ans.70397","url":null,"abstract":"<p><strong>Background: </strong>Transanal opening of the intersphincteric space (TROPIS) has recently emerged as a sphincter-preserving option for the treatment of complex anal fistulas. Although high success rates have been reported in large international series, data on long-term real-world outcomes remain limited. This study aimed to evaluate long-term results of TROPIS, focusing on recurrence and continence, and to compare them with existing literature.</p><p><strong>Methods: </strong>This retrospective single-center cohort included 28 patients who underwent the TROPIS procedure between 2020 and 2023. Demographic data, Parks classification of fistula, operative details, recurrence rates, healing times, and continence outcomes were analyzed. Recurrence was defined as the reappearance of fistula after initial complete healing. Continence was assessed using the Wexner score. Patients were followed with a mean follow-up of 680 ± 120 days.</p><p><strong>Results: </strong>The mean age was 42.6 years. According to Parks' classification, 21 patients (75%) had transsphincteric, 5 (17.9%) extrasphincteric, and 2 (7.1%) complex transsphincteric (horseshoe variant). The average healing time was 36 days. No recurrence occurred within the first 90 days; thereafter, 9 patients (32.1%) developed recurrence (median 225 days, range 90-660). Early postoperative mild incontinence occurred in 42.9% of patients, but only 5 (17.8%) reported persistent mild symptoms at long-term follow-up. No major incontinence was recorded.</p><p><strong>Conclusion: </strong>TROPIS appears to be a safe, sphincter-preserving technique for complex anal fistulas, providing acceptable healing with preserved continence. However, recurrence rates in this cohort were higher than those reported internationally, underscoring the need for careful patient selection, surgical expertise, and adequate long-term follow-up.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145628055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}